Part,  Chapter, Paragraph

1   II,     5.  5.  3|   results in 8.7 to 9.3 million (Dorsey et al, 2007). The burden
2   II,     5.  5.  3| Pharmacoeconomics 14(3):299-312.~Dorsey ER, Constantinescu R, Thompson